Target intelligence / Profile preview

Short ragweed pollen allergen Amb a 9 and Amb a 10 (Amb a 9/10)

Target
Amb a 9/10
Molecular classification
Other, Calcium-binding protein, Polcalcin, Pan-allergen
01

Overview

Amb a 9 and Amb a 10 are calcium-binding proteins, specifically polcalcins, found in the pollen of Ambrosia artemisiifolia (short ragweed). They are classified as minor allergens and pan-allergens due to their high degree of cross-reactivity with polcalcins from other plant species, such as mugwort, birch, and olive. In sensitized individuals, these proteins trigger Type I hypersensitivity reactions by binding to IgE on the surface of mast cells and basophils, leading to the release of inflammatory mediators like histamine. Clinically, they contribute to symptoms of allergic rhinitis and asthma during the ragweed pollination season. While Amb a 1 is the primary focus of ragweed allergy management, Amb a 9 and 10 are important for component-resolved diagnosis to identify patients with broad cross-reactivity. They are present in therapeutic ragweed pollen extracts used in allergen-specific immunotherapy (AIT), which aims to desensitize the immune system and induce long-term tolerance by shifting the immune response from a Th2-mediated profile to a Treg/Th1-mediated profile.

Other names
PolcalcinCalcium-binding protein from short ragweedRagweed pan-allergenAmb a 9.0101Amb a 10.0101
02

Mechanism of action

Allergen-specific immunotherapy (AIT) induces immune tolerance by shifting the immune response from a Th2-mediated allergic profile to a Treg/Th1-mediated profile, increasing the production of IgG4 blocking antibodies and reducing IgE-mediated mast cell degranulation.

03

Biological functions

Immune responseOther
04

Disease associations

InflammationOther
05

Safety considerations

AnaphylaxisSystemic allergic reactionsLocal oral or sublingual allergic reactions (e.g., oral pruritus)Eosinophilic esophagitis (rare risk associated with sublingual immunotherapy)
06

Interacting drugs

Short ragweed pollen allergen extract

1 more in the full profile.

07

Biomarkers

Specific IgE (sIgE) to Amb a 9Specific IgE (sIgE) to Amb a 10Specific IgG4 to ragweed allergensSkin prick test (SPT) reactivityBasophil activation test (BAT)

Beyond the preview

Go deeper on Short ragweed pollen allergen Amb a 9 and Amb a 10 (Amb a 9/10).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Short ragweed pollen allergen Amb a 9 and Amb a 10 (Amb a 9/10).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call